Diagnostic HYBRIDS Announces FDA Clearance Of D3(R) FastPointTM L-DFATM Respiratory Virus Identification Kit

Diagnostic HYBRIDS, a leading developer of IVD fluorescent staining kits and cell culture products, announced the U.S.